Fig. 1.

Long-axis two-dimensional echocardiograms (diastole phase) of patients with cardiomyopathies. a: a cardiac amyloidosis patient with concentric left ventricular (LV) hypertrophy, b: a cardiac amyloidosis patient with asymmetric septal hypertrophy (ASH) at first glance (but actually concentric hypertrophy rather than ASH if moderator band is removed), c: a cardiac Fabry patient with concentric LV hypertrophy, d: a cardiac Fabry patient with ASH (in a terminal stage patient with Fabry disease, LV systolic dysfunction with localized thinning of the base of the LV posterior wall is seen.), e: a hypertrophic cardiomyopathy (HCM) patient with ASH, f: a HCM patient with concentric LV hypertrophy at first glance